{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fskinandjointspodcast.simplecast.com%2Fepisodes%2Fworldpsoday-_ggXqyir","width":444,"version":"1.0","type":"rich","title":"World Psoriasis Day: From Stigma to Skin Clearance with Dr. Jessica Asgarpour","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/017450d4-6458-4a10-9297-ca289770dc2d/f2e428a1-92d7-49e7-ba68-35710b488523/skinnew.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"","height":200,"description":"🎙️World Psoriasis Day Special: Clearer Skin, Brighter Outlook Featuring Dr. Jessica Asgarpour \n\nThis special World Psoriasis Day episode of the Skin and Joints Podcast shines a light on the evolving psoriasis journey—from the first plaque to total skin clearance. Dermatologist Dr. Jessica Asgarpour, now back in her sunny hometown of Calgary, for an honest, hopeful conversation about how far psoriasis care has come—and where it’s headed next.\n\nFrom coal tar and cumbersome creams to once-every-12-week biologic injections, Dr. Asgarpour unpacks the “treatment ladder” and what really determines when to climb it. \n\nWe deep dive into:\n\nWhy World Psoriasis Day (Oct 29) matters for awareness, stigma reduction, and timely re-referral\nHow to recognize when a patient is undertreated and ready for escalation\nThe topical-to-systemic continuum—including steroid-free innovations, orals vs. biologics, and the occasional role for IV therapy\nReal-world barriers in access and adherence—from referral deserts to needle phobia\nMatching therapy to patient lifestyle, comorbidities, and comfort level (“the clinic playbook”)\nWhy dermatologists today can say, confidently, that there is hope for every patient\n\nIt’s part myth-busting, part motivation—a must-listen whether you’re a clinician optimizing care or a patient ready to revisit your treatment options.\n\n🎯 Learning Objectives\n\nAfter listening to this episode, participants will be able to:\nDescribe the modern therapeutic ladder for psoriasis, from topicals and orals to biologics and infusions.\nIdentify clinical and quality-of-life criteria that signal the need for treatment escalation.\nDiscuss common barriers leading to undertreatment and strategies to enhance patient access and adherence.\nCompare classes of biologic agents (TNF-α, IL-17, IL-23, IL-12/23) and their practical considerations in real-world care.\nEmpower patients with evidence-based reassurance about safety, efficacy, and long-term outcomes of advanced therapies.\n\n🩵 World Psoriasis Day is more than awareness—it’s a call to action for clear skin, renewed confidence, and collaborative care.\n#WorldPsoriasisDay #SkinAndJointsPodcast #PsoriasisAwareness #Dermatology #Biologics #PatientJourney #ClearSkinAhead\n\nSupported by SUN Pharma.\n\nABOUT Dr. Jessica Asgarpour \nDermatologist, Calgary, AB\n\nBoard-certified in both Canada and the U.S., Dr. Asgarpour completed medical school at the Cumming School of Medicine and her Dermatology residency at the University of Alberta. She practices medical, surgical, and cosmetic dermatology with a special interest in hidradenitis suppurativa and deroofing surgeries, as well as acne, psoriasis, eczema, skin cancer, and women’s health. She is currently working at the Skin Health and Wellness Centre in Calgary. She is a lecturer at the University of Toronto, a courtesy clinical associate at Women’s College Hospital, and is an active investigator for ongoing clinical trials in inflammatory diseases. She is a board member on the Canadian Hidradenitis Suppurativa foundation."}